Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Mir106a (microRNA 106a) Rattus norvegicus
Analyze
Symbol: Mir106a
Name: microRNA 106a
Description: Predicted to be involved in several processes, including cellular response to forskolin; cellular response to leukemia inhibitory factor; and long-term synaptic potentiation. Predicted to localize to RISC complex and extracellular exosome. Orthologous to human MIR106A (microRNA 106a); PARTICIPATES IN Parkinson's disease pathway; INTERACTS WITH tamoxifen; all-trans-retinoic acid (ortholog); arsane (ortholog).
Type: ncrna
RefSeq Status: PROVISIONAL
Also known as: microRNA 17-2; microRNA mir-17-2; Mir17-2; rno-mir-17-2
Orthologs:
Homo sapiens (human) : MIR106A (microRNA 106a)  HGNC  Alliance
Mus musculus (house mouse) : Mir106a (microRNA 106a)  MGI  Alliance
more info ...
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0X140,117,891 - 140,117,968 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 EnsemblX140,117,891 - 140,117,968 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0X140,167,738 - 140,167,815 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
CeleraX131,322,799 - 131,322,876 (-)NCBICelera
Cytogenetic MapXq36NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
Molecular Pathway Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
QTLs in Region (Rnor_6.0)
miRNA Target Status

Expression

RNA-SEQ Expression

Sequence

Nucleotide Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 6.0)

Additional Information

External Database Links
Nomenclature History
 
More on Mir106a
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 2325506
Created: 2010-06-02
Species: Rattus norvegicus
Last Modified: 2020-06-09
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.